New TAVALISSE® Data Analyses To Be Presented at International Society on Thrombosis and Haemostasis (ISTH) 2021 CongressPRNewsWire • 07/14/21
Rigel Pharmaceuticals: A Patented FDA Approved Drug That May Successfully Fight COVID-19Seeking Alpha • 06/14/21
Rigel Pharmaceuticals, Inc. (RIGL) CEO Raul Rodriguez on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/06/21
Rigel Pharmaceuticals (RIGL) Tops Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/05/21
Rigel Announces Conference Call and Webcast to Report First Quarter 2021 Financial Results and Business UpdatePRNewsWire • 04/28/21
Positive Topline Data Shows Fostamatinib Meets Primary Endpoint of Safety in Phase 2 Clinical Trial in Hospitalized Patients with COVID-19PRNewsWire • 04/13/21
Rigel Announces Completion of Patient Enrollment for NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 PatientsPRNewsWire • 03/11/21
Rigel Pharmaceuticals' (RIGL) CEO Raul Rodriguez on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/03/21
Rigel Pharmaceuticals (RIGL) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 03/02/21
Rigel Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdatePRNewsWire • 03/02/21
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2020 Financial Results and Business UpdatePRNewsWire • 02/23/21